Indeed, we have demonstrated that treatment of STAT1 inhibitor Fludarabine significantly promoted the sensitivity of radioresistant ESCC cell lines and mouse xenografts generated from patient-derived ESCC cells to radiotherapy. The gene discussed is STAT1; the disease is esophageal squamous cell carcinoma.